SLC6A3 and binge eating disorder: Dysregulation of DA signaling (ascribable to either DAT1 polymorphisms or hyper/hypomethylation of DAT1 promoter) is also likely to be involved in eating disorders (EDs), including bulimia nervosa and binge eating disorder [11,12].